Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alnylam
Pharma
JPM26, Day 1: BMS CEO touts portfolio of blockbuster hopefuls
The life sciences industry is heading to San Francisco for the industry's biggest investor event of the year. Check here regularly for updates.
Angus Liu
,
Zoey Becker
,
Kevin Dunleavy
,
Fraiser Kansteiner
,
Eric Sagonowsky
Jan 12, 2026 11:25pm
Alnylam drafts $250M upgrade to its Mass. drug factory
Dec 17, 2025 10:12am
Is Pfizer's recent ATTR sales decline in the US a warning sign?
Dec 2, 2025 8:20am
Alnylam's ATTR-CM launch blows past estimates again
Oct 30, 2025 8:00am
Moderna, Alnylam resolve COVID-19 vaccine patent litigation
Sep 19, 2025 9:40am
Alnylam's market cap jumps past $50B
Aug 1, 2025 7:39am